Journal profile · Pathology
Experimental and Toxicologic Pathology
ISSN 0940-2993 · Urban und Fischer Verlag Jena · GERMANY · Bimonthly · Founded 1992
Experimental and Toxicologic Pathology: subscription journal; review about 1 month (community reports); community-reported acceptance: about 25%; 0 articles in 2025; the journal's website says it has ceased publication.
The journal's website says it has ceased publication: Title discontinued as of 2018 Source ↗Publisher website ·
Scope
Aims, scope and focus
Experimental and Toxicologic Pathology is published by Urban und Fischer Verlag Jena. By OpenAlex counts of its recent articles, its largest topics are Immunotoxicology and immune responses, Carcinogens and Genotoxicity Assessment and Drug-Induced Hepatotoxicity and Protection, together about 40.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Cessation. The international multidisciplinary journal is devoted to the publication of studies covering the whole range of experimental research on disease processes and toxicology including cell biological investigations. Its aim is to support progress in the interdisciplinary cooperation of researchers working in pathobiology, toxicology, and cell biology independent of the methods applied. During the past decades increasing attention has been paid to the importance of toxic influence in the pathogenesis of human and animal diseases. This is why Experimental and Toxicologic Pathology meets the urgent need for an interdisciplinary journal felt by a wide variety of experts in medicine and biology, including pathologists, toxicologists, biologists, physicians, veterinary surgeons, pharmacists, and pharmacologists working in academic, industrial or clinical institutions.
Source: LetPub
Research area (LetPub): Pathology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immunotoxicology and immune responsesImmunology and Microbiology14.9%
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology13.3%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics12%
- Liver physiology and pathologyMedicine5.7%
- Antioxidant Activity and Oxidative StressMedicine5.2%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics4.2%
- Animal testing and alternativesVeterinary3.9%
- Heavy Metal Exposure and ToxicityEnvironmental Science3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pathology and Forensic Medicine | Q2 | 54/184 | — |
| Toxicology | Q2 | 67/114 | — |
| Cell Biology | Q2 | 182/265 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.08LetPub ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.9LetPub ·
- h-index
- 58LetPub ·
- h-index
- 90OpenAlex ·
- i10-index
- 1,222OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 83LetPub ·
Articles by year OpenAlex count · 2,693 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 1,156 |
| 2025 | 0 | 0 | 1,843 |
| 2024 | 0 | 0 | 2,294 |
| 2023 | 0 | 0 | 2,522 |
| 2022 | 0 | 0 | 2,968 |
| 2021 | 0 | 0 | 3,344 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Urban und Fischer Verlag Jena
- Country or region
- GERMANY
- Frequency
- Bimonthly
- Founded
- 1992
- ISSN
- 0940-2993
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Experimental and Toxicologic Pathology
How long does peer review take at Experimental and Toxicologic Pathology?
Authors report an average review time of about 1 month; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Experimental and Toxicologic Pathology open access, and what is the APC?
Experimental and Toxicologic Pathology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .